Main Index   Search   Register   Login   Who's Online   FAQ   Links
  1 Online, 0 Active   You are not logged in  
Main Index     The HIVE light edition (TM)
This is a historical archive
The forum is read-only. Private information has been removed. It is not possible to login.


General Discourse  

    Digest: Richard A. Glennon: literature collection   Please login to post  

 
    Lego
(Hive Bee)
10-25-04 15:00
No 506957
User Picture 
      Richard A. Glennon: literature collection
(Rated as: excellent)
    

The literature was collected with a PubMed search and with the collection on Glennon's Homepage.
All fulltexts available either at the Hive or at Rhodium's page will be hyperlinked.
Suggestions are welcome!

Thanks to 7is, Nicodem and Rhodium for providing scanned articles! cool

Please report dead links either at Post 506981 (Aurelius: "Glennon Digest", General Discourse) or via PM.





Version 1.00: All PubMed entries and articles from Glennon's homepage are collected (new entries compared to the beta version can bee found by the right format)
Version 1.01: All articles were sorted in different chapters, all articles of interest from J. Med. Chem. were uploaded
Version 1.10: All articles retrieved by 7is were uploaded, all entries now have a proper format




Glennon.jpg
Richard A. Glennon's Homepage (http://www.phc.vcu.edu/Faculty/Glennon.html)




5-HT2A/C ligands and other hallucinogens: synthesis and pharmacology

Glennon RA, Bondarev ML, Khorana N, Young R, May JA, Hellberg MR, McLaughlin MA, Sharif NA
beta-Oxygenated Analogues of the 5-HT2A Serotonin Receptor Agonist 1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane
J. Med. Chem., 2004,
DOI:10.1021/jm040082s
Post 537524 (Lego: "Glennon: Oxygenated DOB analogues", Novel Discourse)newbee.jpeg

Peddi S, Roth BL, Glennon RA, Westkaemper RB
Structural determinants for high 5-HT2A receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA)
Bioorg. Med. Chem. Lett., 2004, 14(9), 2279-2283
Medline (PMID=15081025)

Peddi S, Roth BL, Glennon RA, Westkaemper RB
Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist
Eur. J. Pharmacol., 2003, 482(1-3), 335-337
Medline (PMID=14660041)

Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA
Binding of beta-carbolines at 5-HT2 serotonin receptors
Bioorg. Med. Chem. Lett., 2003, 13(24), 4421-4425
Medline (PMID=14643338)
Post 506956 (Lego: "Binding of beta-carbolines at 5-HT2 receptors", General Discourse)

Eckler JR, Chang-Fong J, Rabin RA, Smith C, Teitler M, Glennon RA, Winter JC
Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM
Pharmacol. Biochem. Behav., 2003, 75(4), 845-852
Medline (PMID=12957227)
Post 474567 (Rhodium: "Recent Psychedelic Pharmacology Research", General Discourse)

Peddi S, Roth BL, Glennon RA, Westkaemper RB
Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT2A receptor
Bioorg. Med. Chem. Lett., 2003, 13(15), 2565-2568
Medline (PMID=12852967)

Westkaemper RB, Glennon RA
Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT2A ligands
Curr. Top. Med. Chem., 2002, 2(6), 575-598
Medline (PMID=12052195)
Post 504089 (Lego: "Glennon on SAR and new 5-HT2A ligands", Novel Discourse)

Glennon RA, Metwally K, Dukat M, Ismaiel AM, De los Angeles J, Herndon J, Teitler M, Khorana N
Ketanserin and spiperone as templates for novel serotonin 5-HT2A antagonists
Curr. Top. Med. Chem., 2002, 2(6), 539-558
Medline (PMID=12052193)

Chang-Fong J, Addo J, Dukat M, Smith C, Mitchell NA, Herrick-Davis K, Teitler M, Glennon RA
Evaluation of isotryptamine derivatives at 5-HT2 serotonin receptors
Bioorg. Med. Chem. Lett., 2002, 12(2), 155-158
Medline (PMID=11755343)

Rangisetty JB, Dukat M, Dowd CS, Herrick-Davis K, DuPre A, Gadepalli S, Teitler M, Kelley CR, Sharif NA, Glennon RA
1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT2A serotonin receptor affinity and antagonist character
J. Med. Chem., 2001, 44(20), 3283-3291
Medline (PMID=11563927)


Dowd CS, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA
1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT2A partial agonists
J. Med. Chem., 2000, 43(16), 3074-3084
Medline (PMID=10956215)
https://www.rhodium.ws/pdf/glennon.partial.agonists.pdf

Glennon RA, Dukat M, Grella B, Hong S, Costantino L, Teitler M, Smith C, Egan C, Davis K, Mattson MV
Binding of beta-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors
Drug Alcohol Depend., 2000, 60(2), 121-132
Medline (PMID=10940539)
Post 494854 (Nicodem: "Papers on beta-carbolines", General Discourse)

Kristiansen K, Kroeze WK, Willins DL, Gelber EI, Savage JE, Glennon RA, Roth BL
A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT2A serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism
J. Pharmacol. Exp. Ther., 2000, 293(3), 735-746
Medline (PMID=10869371)

Westkaemper RB, Runyon SP, Bondarev ML, Savage JE, Roth BL, Glennon RA
9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist
Eur. J. Pharmacol., 1999, 380(1), R5-7
Medline (PMID=10513561)

Nelson DL, Lucaites VL, Wainscott DB, Glennon RA
Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors
Naunyn Schmiedebergs Arch. Pharmacol., 1999, 359(1), 1-6
Medline (PMID=9933142)

Metwally KA, Dukat M, Egan CT, Smith C, DuPre A, Gauthier CB, Herrick-Davis K, Teitler M, Glennon RA
Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding
J. Med. Chem., 1998, 41(25), 5084-5093
Medline (PMID=9836624)

Egan CT, Herrick-Davis K, Miller K, Glennon RA, Teitler M
Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors
Psychopharm. (Berl)., 1998, 136(4), 409-414
Medline (PMID=9600588)

Ismaiel AM, Arruda K, Teitler M, Glennon RA
Ketanserin analogues: the effect of structural modification on 5-HT2 serotonin receptor binding
J. Med. Chem., 1995, 38(7), 1196-1202
Medline (PMID=7707322)

Choudhary MS, Sachs N, Uluer A, Glennon RA, Westkaemper RB, Roth BL
Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding
Mol. Pharmacol., 1995, 47(3), 450-457
Medline (PMID=7700242)

Glennon RA, Dukat M, el-Bermawy M, Law H, De los Angeles J, Teitler M, King A, Herrick-Davis K
Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines
J. Med. Chem., 1994, 37(13), 1929-1935
Medline (PMID=8027974)
Post 495672 (scarmani: "N-(4-Bromobenzyl)-5-methoxytryptamine Bioassay", General Discourse)

Westkaemper RB, Glennon RA
Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors
NIDA Res Monogr., 1994, 146, 263-283
Medline (PMID=8742803)

Ismaiel AM, De Los Angeles J, Teitler M, Ingher S, Glennon RA
Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist
J. Med. Chem., 1993, 36(17), 2519-2525
Medline (PMID=8355253)


Herndon JL, Ismaiel A, Ingher SP, Teitler M, Glennon RA
Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding
J. Med. Chem., 1992, 35(26), 4903-4910
Medline (PMID=1479590)

Darmani NA, Martin BR, Glennon RA
Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function
Pharmacol. Biochem. Behav., 1992, 41(3), 519-527
Medline (PMID=1584831)
Post 512438 (7is: "All the missing PBB articles part 1", General Discourse)

Glennon RA, Raghupathi R, Bartyzel P, Teitler M, Leonhardt S
Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity
J. Med. Chem., 1992, 35(4), 734-740
Medline (PMID=1542100)
http://nic-nac-project.de/~tajkor/jm00082a014.pdf

Darmani NA, Martin BR, Pandey U, Glennon RA
Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A receptors
Pharmacol. Biochem. Behav., 1991, 38(2), 353-367
Medline (PMID=1676173)
Post 512438 (7is: "All the missing PBB articles part 1", General Discourse)

Appel NM, Mitchell WM, Garlick RK, Glennon RA, Teitler M, De Souza EB
Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain
J. Pharmacol. Exp. Ther., 1990, 255(2), 843-857
Medline (PMID=2243353)

Glennon RA, Chaurasia C, Titeler M
Binding of indolylalkylamines at 5-HT2 serotonin receptors: examination of a hydrophobic binding region
J. Med. Chem., 1990, 33(10), 2777-2784
Medline (PMID=2213830)


Glennon RA
Do classical hallucinogens act as 5-HT2 agonists or antagonists?
Neuropsychopharmacology, 1990, 3(5-6), 509-517
Medline (PMID=2078284)

Darmani NA, Martin BR, Glennon RA
Withdrawal from chronic treatment with (+/-)-DOI causes super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in mice
Eur. J. Pharmacol., 1990, 186(1), 115-118
Medline (PMID=2282932)

Darmani NA, Martin BR, Pandey U, Glennon RA
Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
Pharmacol. Biochem. Behav., 1990, 36(4), 901-906
Medline (PMID=2145593)
Post 512438 (7is: "All the missing PBB articles part 1", General Discourse)

Seggel MR, Yousif MY, Lyon RA, Titeler M, Roth BL, Suba EA, Glennon RA
A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors
J. Med. Chem., 1990, 33(3), 1032-1036
Medline (PMID=2308135)
https://www.rhodium.ws/pdf/glennon.sar.4-subst.pea.pdf

Sadzot B, Baraban JM, Glennon RA, Lyon RA, Leonhardt S, Jan CR, Titeler M
Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis
Psychopharm. (Berl)., 1989, 98(4), 495-499
Medline (PMID=2505289)

Lyon RA, Titeler M, Seggel MR, Glennon RA
Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens
Eur. J. Pharmacol., 1988, 145(3), 291-297
Medline (PMID=3350047)

Glennon RA, Seggel MR, Soine WH, Herrick-Davis K, Lyon RA, Titeler M
[125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors
J. Med. Chem., 1988, 31(1), 5-7
Medline (PMID=3336031)
https://www.rhodium.ws/pdf/glennon.doi-125.pdf

Titeler M, Lyon RA, Glennon RA
Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens
Psychopharm. (Berl)., 1988, 94(2), 213-216
Medline (PMID=3127847)

Titeler M, Lyon RA, Davis KH, Glennon RA
Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand
Biochem Pharmacol., 1987, 36(19), 3265-3271
Medline (PMID=3663239)

Seggel MR, Qureshi GD, Glennon RA
Effect of 5-HT2-selective agonists on cat platelet aggregation
Life Sci., 1987, 41(9), 1077-1081
Medline (PMID=3613863)
Post 508288 (7is: "All the missing Life Sciences articles part 2", General Discourse)

Glennon RA, Titeler M, Seggel MR, Lyon RA
N-methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane
J. Med. Chem., 1987, 30(5), 930-932
Medline (PMID=3572981)


Rasmussen K, Glennon RA, Aghajanian GK
Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity
Eur. J. Pharmacol., 1986, 132(1), 79-82
Medline (PMID=3816969)

Glennon RA, Slusher RM, Lyon RA, Titeler M, McKenney JD
5-HT1 and 5-HT2 binding characteristics of some quipazine analogues
J. Med. Chem., 1986, 29(11), 2375-2380
Medline (PMID=3783595)


Young R, Rosecrans JA, Glennon RA
Further studies on the dose-dependent stimulus properties of 5-methoxy-N,N-dimethyltryptamine
Pharmacol. Biochem. Behav., 1986 , 25(6), 1207-1210
Medline (PMID=3809222)
Post 512438 (7is: "All the missing PBB articles part 1", General Discourse)

Glennon RA
Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)
Life Sci., 1986, 39(9), 825-830
Medline (PMID=2943960)
Post 508288 (7is: "All the missing Life Sciences articles part 2", General Discourse)

Glennon RA
Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT)
Pharmacol. Biochem. Behav., 1986, 25(1), 135-139
Medline (PMID=2944129)
Post 512438 (7is: "All the missing PBB articles part 1", General Discourse)

Glennon RA
Discriminative stimulus properties of phenylisopropylamine derivatives
Drug Alcohol Depend., 1986, 17(2-3), 119-134
Medline (PMID=2874967)

Glennon RA, McKenney JD, Lyon RA, Titeler M
5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues
J. Med. Chem., 1986, 29(1), 194-199
Medline (PMID=3950904)


Glennon RA, Titeler M, Young R
Structure-activity relationships and mechanism of action of hallucinogenic agents based on drug discrimination and radioligand binding studies
Psychopharmacol Bull., 1986, 22(3), 953-958
Medline (PMID=3025916)

Glennon RA, Hauck AE
Mechanistic studies on DOM as a discriminative stimulus
Pharmacol. Biochem. Behav., 1985, 23(6), 937-941
Medline (PMID=2934750)
Post 512438 (7is: "All the missing PBB articles part 1", General Discourse)

Glennon RA, Young R, Hauck AE
Structure-activity studies on methoxy-substituted phenylisopropylamines using drug discrimination methodology
Pharmacol. Biochem. Behav., 1985, 22(5), 723-729
Medline (PMID=3839309)
Post 512438 (7is: "All the missing PBB articles part 1", General Discourse)

Glennon RA, Titeler M, McKenney JD
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
Life Sci., 1984, 35(25), 2505-2511
Medline (PMID=6513725)
Post 508287 (not existing)

Glennon RA, Jacyno JM, Young R, McKenney JD, Nelson D
Synthesis and evaluation of a novel series of N,N-dimethylisotryptamines
J. Med. Chem., 1984, 27(1), 41-45
Medline (PMID=6581313)


Glennon RA, Jacyno JM, Young R
A comparison of the behavioral properties of (±)-, (-)-, and (+)-5-methoxy-alpha-methyltryptamine
Biol. Psychiatry., 1983, 18(4), 493-498
Medline (PMID=6860723)

Glennon RA, Young R, Jacyno JM
Indolealkylamine and phenalkylamine hallucinogens. Effect of alpha-methyl and N-methyl substituents on behavioral activity
Biochem Pharmacol. 1983, 32(7), 1267-1273
Medline (PMID=6573879)
https://www.rhodium.ws/pdf/butanamines/butanamines_1983_BP.pdf

Glennon RA, Young R, Jacyno JM, Slusher M, Rosecrans JA
DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines
Eur. J. Pharmacol., 1983, 86(3-4), 453-459
Medline (PMID=6572591)

Young R, Rosecrans JA, Glennon RA
Behavioral effects of 5-methoxy-N,N-dimethyltryptamine and dose-dependent antagonism by BC-105
Psychopharm. (Berl)., 1983, 80(2), 156-160
Medline (PMID=6410445)

Kline TB, Benington F, Morin RD, Beaton JM, Glennon RA, Domelsmith LN, Houk KN, Rozeboom MD
Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives
J. Med. Chem., 1982, 25(11), 1381-1383
Medline (PMID=6815326)


Glennon RA, Young R, Benington F, Morin RD
Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane
J. Med. Chem., 1982, 25(10), 1163-1168
Medline (PMID=7143352)
https://www.rhodium.ws/pdf/glennon.4-pos-sar.dof-doi-don.pdf

Glennon RA, Young R
Comparison of behavioral properties of di- and tri-methoxyphenylisopropylamines
Pharmacol. Biochem. Behav., 1982, 17(4), 603-607
Medline (PMID=6965276)
Post 512438 (7is: "All the missing PBB articles part 1", General Discourse)

Glennon RA, Gessner PK, Godse DD, Kline BJ
Bufotenine esters
J. Med. Chem., 1979, 22(11), 1414-1416
Medline (PMID=533890)


Grella B, Dukat M, Young R, Teitler M, Herrick-Davis K, Gauthier CB, Glennon RA
Investigation of hallucinogenic and related beta-carbolines
Drug Alcohol Depend., 1998, 50(2), 99-107
Medline (PMID=9649961)
Post 494854 (Nicodem: "Papers on beta-carbolines", General Discourse)

Glennon RA
Classical hallucinogens: an introductory overview
NIDA Res Monogr., 1994, 146, 4-32
Medline (PMID=8742792)

Glennon RA, Teitler M, Sanders-Bush E
Hallucinogens and serotonergic mechanisms
NIDA Res Monogr., 1992, 119, 131-135
Medline (PMID=1435968)

Glennon RA
Phenylalkylamine stimulants, hallucinogens, and designer drugs
NIDA Res Monogr., 1991, 105, 154-160
Medline (PMID=1678860)

Darmani NA, Martin BR, Pandey U, Glennon RA
Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions
Pharmacol. Biochem. Behav., 1990, 37(1), 95-99
Medline (PMID=2263671)
Post 512438 (7is: "All the missing PBB articles part 1", General Discourse)

Glennon RA
Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: formulation of structure-activity relationships
NIDA Res Monogr., 1989, 94, 43-67
Medline (PMID=2575229)

Glennon RA, Titeler M, Lyon RA
A preliminary investigation of the psychoactive agent 4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse
Pharmacol. Biochem. Behav., 1988, 30(3), 597-601
Medline (PMID=3211969)
https://www.rhodium.ws/pdf/glennon.2c-b.pdf

Glennon RA, Titeler M, Lyon RA, Slusher RM
N,N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin
J. Med. Chem., 1988, 31(4), 867-870
Medline (PMID=2965244)


Titeler M, Herrick K, Lyon RA, McKenney JD, Glennon RA
[3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors
Eur. J. Pharmacol., 1985, 117(1), 145-146
Medline (PMID=4085543)

Glennon RA, Jacyno JM, Young R
A comparison of the behavioral properties of (±)-, (-)-, and (+)-5-methoxy-alpha-methyltryptamine
Biol. Psychiatry., 1983, 18(4), 493-498
Medline (PMID=6860723)

Young R, Rosecrans JA, Glennon RA
Comparative discriminative stimulus effects of 5-methoxy-N,N-dimethyltryptamine and LSD
Life Sci., 1982, 30(24), 2057-2062
Medline (PMID=7109835)
Post 508287 (not existing)

Glennon RA, Young R, Rosecrans JA
A comparison of the behavioral effects of DOM homologs
Pharmacol. Biochem. Behav., 1982, 16(4), 557-559
Medline (PMID=7071089)
Post 512438 (7is: "All the missing PBB articles part 1", General Discourse)

Glennon RA, Young R, Rosecrans JA
Discriminative stimulus properties of DOM and several molecular modifications
Pharmacol. Biochem. Behav., 1982, 16(4), 553-536
Medline (PMID=7071088)
Post 512438 (7is: "All the missing PBB articles part 1", General Discourse)

Glennon RA, Young R, Benington F, Morin RD
Hallucinogens as discriminative stimuli: a comparison of 4-OMe DMT and 5-OMe DMT with their methythio counterparts
Life Sci., 1982, 30(5), 465-467
Medline (PMID=6801410)
Post 508287 (not existing)

Glennon RA, Rosecrans JA
Indolealkylamine and phenalkylamine hallucinogens: a brief overview
Neurosci. Biobehav. Rev., 1982, 6(4), 489-497
Medline (PMID=6757811)

Glennon RA, Rosecrans JA, Young R
Behavioral properties of psychoactive phenylisopropylamines in rats
Eur. J. Pharmacol., 1981, 76(4), 353-360
Medline (PMID=7327208)

Domelsmith LN, Eaton TA, Houk KN, Anderson GM 3rd, Glennon RA, Shulgin AT, Castagnoli N Jr, Kollman PA
Photoelectron spectra of psychotropic drugs. 6. Relationships between the physical properties and pharmacological actions of amphetamine analogues
J. Med. Chem., 1981, 24(12), 1414-1421
Medline (PMID=7310818)
https://www.rhodium.ws/pdf/drugs.photoelectron.spectra-6.pdf

Glennon RA, Doot DL, Young R
DOM and related 2,5-dimethoxy-4-alkylphenylisopropylamines: behavioral and serotonin receptor properties
Pharmacol. Biochem. Behav., 1981, 14(3), 287-292
Medline (PMID=7232455)
Post 512466 (7is: "All the missing PBB articles part 2", General Discourse)
 
Glennon RA, Rosecrans JA
Speculations on the mechanism of action of hallucinogenic indolealkylamines
Neurosci. Biobehav. Rev., 1981, 5(2), 197-207
Medline (PMID=7022271)

Glennon RA, Liebowitz SM, Leming-Doot D, Rosecrans JA
Demethyl analogues of psychoactive methoxyphenalkylamines: synthesis and serotonin receptor affinities
J. Med. Chem., 1980, 23(9), 990-994
Medline (PMID=7411554)


Glennon RA, Liebowitz SM, Anderson GM 3rd
Serotonin receptor affinities of psychoactive phenalkylamine analogues
J. Med. Chem., 1980, 23(3), 294-299
Medline (PMID=7365744)
https://www.rhodium.ws/pdf/glennon.pea.receptor.affinities.pdf

Minnema D, Krynock G, Young R, Glennon R, Rosecrans J
LSD as a discriminative stimulus: role of dorsal raphe nucleus
Subst Alcohol Actions Misuse., 1980, 1(1), 29-34
Medline (PMID=7323940)

Young R, Glennon RA, Rosecrans JA
Discriminative stimulus properties of the hallucinogenic agent DOM
Commun. Psychopharmacol., 1980, 4(6), 501-506
Medline (PMID=7297054)

Glennon RA, Young R, Rosecrans JA, Kallman MJ
Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities
Psychopharm. (Berl)., 1980, 68(2), 155-158
Medline (PMID=6776558)

Glennon RA, Kier LB, Shulgin AT
Molecular connectivity analysis of hallucinogenic mescaline analogs
J. Pharm. Sci., 1979, 68(7), 906-907
Medline (PMID=458614)
https://www.rhodium.ws/pdf/shulgin/shulgin.molecular.connectivity.pdf

Glennon RA, Gessner PK
Serotonin receptor binding affinities of tryptamine analogues
J. Med. Chem., 1979, 22(4), 428-432
Medline (PMID=430481)


Glennon RA, Rosecrans JA, Young R, Gaines J
Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus
Life Sci., 1979, 24(11), 993-997
Medline (PMID=286864)
Post 508287 (not existing)

Glennon RA, Liebowitz SM, Mack EC
Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues
J. Med. Chem., 1978, 21(8), 822-825
Medline (PMID=278843)
(Uploaded file not existing)

Kier LB, Glennon RA
Psychotomimetic phenalkylamines as serotonin agonists: an SAR analysis
Life Sci., 1978, 22(18), 1589-1593
Medline (PMID=672414)
Post 508287 (not existing)

Kier LB, Glennon RA
Progress with several models for the study of the SAR of hallucinogenic agents
NIDA Res. Monogr., 1978, (22), 159-185
Medline (PMID=101879)

Glennon RA, Gessner PK
The electronic and serotonin receptor binding affinity properties of N,N-dimethyltryptamine analogs
Res. Commun. Chem. Pathol. Pharmacol., 1977, 18(3), 453-465
Medline (PMID=270770)

Glennon RA
A quantum chemical investigation of the pi-electronic structure of the hallucinogenic N,N-dimethyltryptamines
Res. Commun. Chem. Pathol. Pharmacol., 1974, 9(1), 185-188
Medline (PMID=4531086)

Glennon, R. A.; Kier, L. B
LSD Analogs as serotonin antagonists: A molecular connectivity SAR analysis
Eur. J. Med. Chem., 1978, 13, 219
No PubMed entry or DOI found

Minnema, D.; Krynock, G.; Young, R.; Glennon, R. A.; Rosecrans, J. A
Role of dorsal raphe neurons to the ability of LSD to act as a discriminative stimulus
J. Alcohol Drug Abuse, 1980, 1, 29
No PubMed entry or DOI found

Westkaemper, R.B.; Dukat, M.; Glennon, R.A
Molecular modeling of drug-receptor interactions using a 5-HT2 receptor model
Med. Chem. Res., 1991, 1, 401-408
No PubMed entry or DOI found

Westkaemper, R.B. and Glennon, R.A
Molecular graphics models of members of the 5-HT2 subfamily: 5-HT2A, 5-HT2B, and 5-HT2C receptors
Med. Chem. Res., 1993, 3, 317-334
No PubMed entry or DOI found

Carroll, F.I.; Glennon, R.A.; Johnson, M.R.; Teitler, M.; Zimmerman, D. M
Hallucinogenic Agents: Drugs of abuse as neurochemical tools
NIDA Res. Mono., 1994, 140, 94-98
No PubMed entry or DOI found

Dukat, M.; Herrick-Davis, K.; Teitler, M.; Glennon, R.A
Piperidine derivatives of serotonin as selective 5-HT1A serotonin receptor agonists
Med. Chem. Res., 1994, 4, 254-258
No PubMed entry or DOI found

Ismaiel, A.M. Dukat, M., Nelson, D.L. Lucaites, V.L.; Glennon, R.A
Binding of N2-substituted pyrio[4,3-b]indole analogs of spiperone at human 5-HT2A, 5-HT2B, and 5-HT2C serotonin receptors
Med. Chem. Res., 1996, 6, 197-211
No PubMed entry or DOI found

Malmusi, L.; Dukat, M.; Young, R.; Teitler, M.; Darmani, N.; Ahmad, B.; Smith, C.; Glennon, R. A
1,2,3,4- Tetrahydroisoquinolines and related analogs of the phenylalkylamine stimulants and hallucinogens
Med. Chem. Res. 1996, 6, 400-411
No PubMed entry or DOI found

Glennon, R. A.; Dukat, M
Novel serotonergic agents: 5-HT2 – Update 1997
Investigational Drugs Research Alerts, 1997, 2, 107-113
No PubMed entry or DOI found

Westkaemper, R. B.; Hyde, E. G.; Choudhary, M. S.; Khan, N.; Gelbar, E.; Glennon, R. A.; Roth, B. L
Engineering a region of bulk tolerance in the 5-HT2A receptor
Eur. J. Med. Chem., 1999, 34, 441-447
No PubMed entry or DOI found

Khorana, N.; Bondarev, M.; Dukat, M.; Herrick-Davis, K.; Egan, C.; DuPre, A.; Smith, C.; Teitler, M.; Glennon, R. A
Binding of spiperone analogs at 5-HT2A serotonin receptors
Med. Chem. Res., 1999, 9, 657-667
No PubMed entry or DOI found

Hong, S.; Dukat, M.; Teitler, M.; Egan, C.; DuPre, A.; Herrick-Davis, K.; Glennon, R. A
5,8-Dimethoxyharmalan: Actions at 5-HT2A serotonin receptors
Med. Chem. Res., 1999, 9, 374-388
No PubMed entry or DOI found

Glennon RA
Arylalkylamine drugs of abuse: an overview of drug discrimination studies
Pharmacol. Biochem. Behav., 1999, 64(2), 251-256
Medline (PMID=10515299)
https://www.rhodium.ws/pdf/glennon.arylalkylamine.drugs.of.abuse.pdf

Darmani NA, Martin BR, Glennon RA
Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin
J. Pharmacol. Exp. Ther., 1992, 262(2), 692-698
Medline (PMID=1501117)

Glennon RA
Discriminative stimulus properties of hallucinogens and related designer drugs
NIDA Res. Monogr., 1991, (116), 25-44
Medline (PMID=1369672)

Higgs RA, Glennon RA
Stimulus properties of ring-methyl amphetamine analogs
Pharmacol. Biochem. Behav., 1990, 37(4), 835-837
Medline (PMID=2093186)
Post 512466 (7is: "All the missing PBB articles part 2", General Discourse)

Nichols DE, Glennon RA
Medicinal chemistry and structure-activity relationships of hallucinogens.
In: Jacobs, B.L., ed. Hallucinogens: Neurochemical, Behavioral, and Clinical Perspectives. New York: Raven Press, 1984. pp. 95-142
No PubMed entry or DOI found
newbee.jpeg





Ligands of other 5-HT receptor subtypes

Pullagurla MR, Westkaemper RB, Glennon RA
Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors
Bioorg. Med. Chem. Lett., 2004, 14(17), 4569-4573
Medline (PMID=15357994)
newbee.jpeg

Prisinzano T, Dukat M, Law H, Slassi A, MacLean N, DeLannoy I, Glennon RA
2-(Anilino)imidazolines and 2-(benzyl)imidazoline derivatives as h5-HT1D serotonin receptor ligands
Bioorg. Med. Chem. Lett., 2004, 14(18), 4697-4699
Medline (PMID=15324890)
newbee.jpeg

Dukat M, Smith C, Herrick-Davis K, Teitler M, Glennon RA
Binding of tryptamine analogs at h5-HT1E receptors: a structure-affinity investigation
Bioorg. Med. Chem., 2004, 12(10), 2545-2552
Medline (PMID=15110837)

Chang-Fong J, Rangisetty JB, Dukat M, Setola V, Raffay T, Roth B, Glennon RA
1,2,3,4-tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands
Bioorg. Med. Chem. Lett., 2004, 14(8), 1961-1964
Medline (PMID=15050637)

Glennon RA, Daoud MK, Dukat M, Teitler M, Herrick-Davis K, Purohit A, Syed H
Arylguanidine and arylbiguanide binding at 5-HT3 serotonin receptors: a QSAR study
Bioorg. Med. Chem., 2003, 11(20), 4449-4454
Medline (PMID=13129581)

Pullagurla MR, Dukat M, Setola V, Roth B, Glennon RA
N1-benzenesulfonylgramine and N1-benzenesulfonylskatole: novel 5-HT6 receptor ligand templates
Bioorg. Med. Chem. Lett., 2003, 13(19), 3355-3359
Medline (PMID=12951125)

Khorana N, Smith C, Herrick-Davis K, Purohit A, Teitler M, Grella B, Dukat M, Glennon RA
Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors
J. Med. Chem., 2003, 46(18):3930-3937
Medline (PMID=12930153)

Glennon RA
Higher-end serotonin receptors: 5-HT5, 5-HT6, and 5-HT7
J. Med. Chem., 2003, 46(14), 2795-2812
Medline (PMID=12825922)

Rahman AA, Daoud MK, Dukat M, Herrick-Davis K, Purohit A, Teitler M, do Amaral AT, Malvezzi A, Glennon RA
Conformationally-restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-chlorophenylbiguanide (mCPBG) and meta-chlorophenylguanidine (mCPG)
Bioorg. Med. Chem. Lett., 2003, 13(6):1119-1123
Medline (PMID=12643925)

Khorana N, Purohit A, Herrick-Davis K, Teitler M, Glennon RA
gamma-Carbolines: binding at 5-HT5A serotonin receptors
Bioorg. Med. Chem., 2003, 11(5), 717-722
Medline (PMID=12538001)

Runyon SP, Peddi S, Savage JE, Roth BL, Glennon RA, Westkaemper RB
Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene
J. Med. Chem., 2002, 45(8), 1656-1664
Medline (PMID=11931619)

Dukat M, Choi YN, Teitler M, Du Pre A, Herrick-Davis K, Smith C, Glennon RA
The binding of arylguanidines at 5-HT3 serotonin receptors: a structure-affinity investigation
Bioorg. Med. Chem. Lett., 2001, 11(12), 1599-1603
Medline (PMID=11412989)

Prisinzano T, Law H, Dukat M, Slassi A, MaClean N, Demchyshyn L, Glennon RA
Imidazoline-modified benzylimidazolines as h5-HT1D/1B serotonergic ligands
Bioorg. Med. Chem., 2001, 9(3):613-619
Medline (PMID=11310595)

Runyon SP, Savage JE, Taroua M, Roth BL, Glennon RA, Westkaemper RB
Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene
Bioorg. Med. Chem. Lett., 2001, 11(5), 655-658
Medline (PMID=11266163)

Westkaemper RB, Runyon SP, Savage JE, Roth BL, Glennon RA
Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor
Bioorg. Med. Chem. Lett., 2001, 11(4), 563-566
Medline (PMID=11229772)

Tsai Y, Dukat M, Slassi A, MacLean N, Demchyshyn L, Savage JE, Roth BL, Hufesein S, Lee M, Glennon RA
N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonistst
Bioorg. Med. Chem. Lett., 2000, 10(20), 2295-2299
Medline (PMID=11055342)

Dukat M, Young R, Darmani NN, Ahmed B, Glennon RA
The 5-HT3 agent N-(3-chlorophenyl)guanidine (MD-354) serves as a discriminative stimulus in rats and displays partial agonist character in a shrew emesis assay
Psychopharm. (Berl)., 2000, 150(2), 200-207
Medline (PMID=10907673)

Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK
2-Substituted tryptamines: agents with selectivity for 5-HT6 serotonin receptors
J. Med. Chem., 2000, 43(5), 1011-1018
Medline (PMID=10715164)
http://pharmacist8.tripod.com/2-subst-trypt.pdf

Law H, Dukat M, Teitler M, Lee DK, Mazzocco L, Kamboj R, Rampersad V, Prisinzano T, Glennon RA
Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation
J. Med. Chem., 1998, 41(13), 2243-2251
Medline (PMID=9632357)

Ismaiel AM, Dukat M, Law H, Kamboj R, Fan E, Lee DK, Mazzocco L, Buekschkens D, Teitler M, Pierson ME, Glennon RA
2-(1-Naphthyloxy)ethylamines with enhanced affinity for human 5-HT1D beta (h5-HT1B) serotonin receptors
J. Med. Chem., 1997, 40(26), 4415-4419
Medline (PMID=9435911)

Dukat M, Abdel-Rahman AA, Ismaiel AM, Ingher S, Teitler M, Gyermek L, Glennon RA
Structure-activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors
J. Med. Chem., 1996, 39(20), 4017-4026
Medline (PMID=8831767)
https://www.rhodium.ws/pdf/glennon.arylpiperazines.5ht3.pdf

Glennon RA, Hong SS, Bondarev M, Law H, Dukat M, Rakhi S, Power P, Fan E, Kinneau D, Kamboj R, Teitler M, Herrick-Davis K, Smith C
Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors
J. Med. Chem., 1996, 39(1), 314-322
Medline (PMID=8568822)

Glennon RA, Hong SS, Dukat M, Teitler M, Davis K
5-(Nonyloxy)tryptamine: a novel high-affinity 5-HT1D beta serotonin receptor agonist
J. Med. Chem., 1994, 37(18), 2828-2830
Medline (PMID=8071931)

Glennon RA, Young R, Dukat M
5-HT3 agonist 2-methylserotonin as a training drug in discrimination studies
Pharmacol. Biochem. Behav., 1992, 41(2), 361-364
Medline (PMID=1574526)
Post 512466 (7is: "All the missing PBB articles part 2", General Discourse)

Westkaemper RB, Glennon RA
Approaches to molecular modeling studies and specific application to serotonin ligands and receptors
Pharmacol. Biochem. Behav., 1991, 40(4), 1019-1031
Medline (PMID=1816556)
Post 512466 (7is: "All the missing PBB articles part 2", General Discourse)

Glennon RA, Dukat M
Serotonin receptors and their ligands: a lack of selective agents
Pharmacol. Biochem. Behav., 1991, 40(4), 1009-1017
Medline (PMID=1816555)
Post 512466 (7is: "All the missing PBB articles part 2", General Discourse)

Raghupathi RK, Rydelek-Fitzgerald L, Teitler M, Glennon RA
Analogues of the 5-HT1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced alpha 1-adrenergic affinity
J. Med. Chem., 1991, 34(8), 2633-2638
Medline (PMID=1652026)

Glennon RA
Serotonin receptors and site-selective agents
J. Physiol. Pharmacol., 1991, 42(1), 49-60
Medline (PMID=1932772)

Glennon RA, Darmani NA, Martin BR
Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents
Life Sci., 1991, 48(26), 2493-2498
Medline (PMID=2046474)
Post 508288 (7is: "All the missing Life Sciences articles part 2", General Discourse)

Rydelek-Fitzgerald L, Teitler M, Fletcher PW, Ismaiel AM, Glennon RA
NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors
Brain Res., 1990, 532(1-2), 191-196
Medline (PMID=2282513)

Ismaiel AM, Titeler M, Miller KJ, Smith TS, Glennon RA
5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin
J. Med. Chem., 1990, 33(2), 755-758
Medline (PMID=2299641)


Glennon RA
Serotonin receptors: clinical implications
Neurosci. Biobehav. Rev., 1990, 14(1), 35-47
Medline (PMID=2183098)

Glennon RA, Ismaiel AE, McCarthy BG, Peroutka SJ
Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study
Eur. J. Pharmacol., 1989, 168(3), 387-392
Medline (PMID=2583244)

Glennon RA, Naiman NA, Pierson ME, Smith JD, Ismaiel AM, Titeler M, Lyon RA
N-(phthalimidoalkyl) derivatives of serotonergic agents: a common interaction at 5-HT1A serotonin binding sites?
J. Med. Chem., 1989, 32(8), 1921-1926
Medline (PMID=2754715)


Pierson ME, Lyon RA, Titeler M, Schulman SB, Kowalski P, Glennon RA
Design and synthesis of propranolol analogues as serotonergic agents
J. Med. Chem., 1989, 32(4), 859-863
Medline (PMID=2539480)


Naiman N, Lyon RA, Bullock AE, Rydelek LT, Titeler M, Glennon RA
2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites
J. Med. Chem., 1989, 32(1), 253-256
Medline (PMID=2521252)

Glennon RA, Naiman NA, Lyon RA, Titeler M
Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands
J. Med. Chem., 1988, 31(10), 1968-1971
Medline (PMID=3172131)

Glennon RA, Naiman NA, Pierson ME, Titeler M, Lyon RA, Weisberg E
NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)
Eur. J. Pharmacol., 1988, 154(3), 339-341
Medline (PMID=2976673)

Glennon RA
Site-selective serotonin agonists as discriminative stimuli
Psychopharmacol. Ser., 1988, 4, 15-31
Medline (PMID=3293039)

Glennon RA
Central serotonin receptors as targets for drug research
J. Med. Chem., 1987, 30(1), 1-12
Medline (PMID=3543362)


Lyon RA, Titeler M, McKenney JD, Magee PS, Glennon RA
Synthesis and evaluation of phenyl- and benzoylpiperazines as potential serotonergic agents
J. Med. Chem., 1986, 29(5), 630-634
Medline (PMID=3701781)


McKenney JD, Glennon RA
TFMPP may produce its stimulus effects via a 5-HT1B mechanism
Pharmacol. Biochem. Behav., 1986, 24(1), 43-47
Medline (PMID=3945665)

Arvidsson LE, Hacksell U, Glennon RA
Recent advances in central 5-hydroxytryptamine receptor agonists and antagonists
Prog. Drug. Res., 1986, 30, 365-471
Medline (PMID=3544048)

Glennon RA, McKenney JD, Young R
Discriminative stimulus properties of the serotonin agonist 1-(3-trifluoromethylphenyl)piperazine (TFMPP)
Life Sci., 1984, 35(14), 1475-1480
Medline (PMID=6482668)
Post 508287 (not existing)

Glennon RA, Young R, Rosecrans JA
Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists
Eur. J. Pharmacol., 1983, 91(2-3), 189-96
Medline (PMID=6617740)

Glennon RA, Jacyno JM, Salley JJ Jr
2,3-dihydro and carbocyclic analogues of tryptamines: interaction with serotonin receptors
J. Med. Chem., 1982, 25(1), 68-70
Medline (PMID=7086824)

Glennon RA
Serotonin receptor interactions of harmaline and several related beta-carbolines
Life Sci., 1981, 29(8), 861-865
Medline (PMID=7300579)
Post 508287 (not existing)

Glennon RA
The effect of chirality on serotonin receptor affinity
Life Sci., 1979, 24(16), 1487-1492
Medline (PMID=470548)
Post 508287 (not existing)

Glennon RA, Martin B, Johnson KM, End D
7,N,N-Trimethyltryptamine: a selective inhibitor of synaptosomal serotonin uptake
Res. Commun. Chem. Pathol. Pharmacol., 1978, 19(1), 161-164
Medline (PMID=625585)

Glennon, R. A.; Naiman, N. A.; Pierson, M. E.; Titeler, M.; Lyon, R. A.; Herndon, J. L.; Misenheimer, B
Stimulus properties of arylpiperazines: NAN-190, a potential 5-HT1A serotonin antagonist
Drug. Dev. Res., 1989, 16, 335-343
No PubMed entry or DOI found

Ismaiel, A. M.; Titeler, M.; Glennon, R. A
g-Carboline derivatives as potential serotonergic agents
Mansoura J. Pharm. (Egypt) 1989, 6, 1-13
No PubMed entry or DOI found

Glennon, R. A., Raghupathi, R. K
Serotonin receptor ligands
Current CNS Patents 1990, 1, 323-343
No PubMed entry or DOI found

Glennon, R.A
Serotonin receptors and site-selective agents
J. Physiol. Pharmacol. (Poland) 1991, 1, 42-60
No PubMed entry or DOI found

Glennon, R. A., Ismaiel, A. M., Chaurasia, C., Titeler, M
5-HT1D serotonin receptors: Results of a structure- affinity investigation
Drug Dev. Res. 1991, 22, 25-36
No PubMed entry or DOI found

Glennon, R.A., El-Ashmawy, M., Ismaiel, A.M., Fischer, J.B
Binding of N-substituted 2-phenylaminoethanes to s and serotonin 5-HT1A receptors
Med. Chem. Res., 1991, 1, 109-114
No PubMed entry or DOI found

Glennon, R.A., Bartyzel, P., Teitler, M
Binding of benz[e]-and benz[g]-fused tryptamine derivatives at serotonin receptors: Evidence for a region of bulk tolerance
Med. Chem. Res., 1991, 1, 201-206
No PubMed entry or DOI found

Glennon, R. A.; Darmani, N.; Martin, W
Modulation of the behavioral effects of serotonergic agents by multiple 5-HT receptors
Life Sci., 1991, 48, 2493-2498
No PubMed entry or DOI found

Dukat, M.; Miller, K.; Teitler, M.; Glennon, R.A
Binding of amine-substituted and quaternary amine analogs of serotonin at 5-HT3 serotonin receptors
Med. Chem. Res., 1991, 1, 271-276
No PubMed entry or DOI found

Bakthavachalam, V.; Fell, B.; Teitler, M.; Glennon, R.A.; Neumeyer, J.L
Fluorescent probes for serotonin 5-HT1A receptors: synthesis, receptor affinity and selectivity
Med. Chem. Res., 1991, 1, 265-270
No PubMed entry or DOI found

Glennon, R.A
Preface for special serotonin issue
Pharmacol. Biochem. Behav., 1991, 40, 1007
No PubMed entry or DOI found

El-Bermawy, M.; Raghupathi, R.; Ingher, S. P.; Teitler, M.; Maayani, S.; Glennon, R. A
4-[4-(1-Noradamantane carboxamido)butyl]-1-(2-methoxyphenyl) piperazine: A high affinity 5-HT1A-selective agent
Med. Chem. Res., 1992, 2, 88-95
No PubMed entry or DOI found

El-Bermawy, M.; Lotter, H.; Glennon, R.A
Comparative molecular field analysis of the binding of arylpiperazines at 5-HT1A serotonin receptors
Med. Chem. Res., 1992, 2, 290-297
No PubMed entry or DOI found

Glennon, R.A
Concepts for design of 5-HT1A serotonin agonists and antagonists
Drug Dev. Res., 1992, 26, 251-274
No PubMed entry or DOI found

Westkaemper, R.B.; Yousif, M.; Teitler, M.; Glennon, R.A
Binding of aporphines at 5-HT1A serotonin receptors: A computational investigation of potential binding modes
Med. Chem. Res., 1992, 2, 482-490
No PubMed entry or DOI found

Glennon, R.A.; Dukat, M
5-HT receptor ligands: Update 1992
Current Drugs, 1992, 1, 1-45
No PubMed entry or DOI found

Glennon, R.A., Westkaemper, R.B
5-HT1D Receptors: A serotonin receptor population for the 1990s
Drug News Perspect., 1993, 6, 390-405
No PubMed entry or DOI found

Hong, S.-S.; Dukat, M.; Teitler, M.; Herrick-Davis, K.; McCallum, K.; Kamboj, R.; Glennon, R.A
Binding of 5-arylalkyloxytryptamines at human 5-HT1Dß serotonin receptors
Med. Chem. Res., 1995, 5, 690-699
No PubMed entry or DOI found

Iwamura, T.; Casey, C. T.; Young, R.; Dukat, M.; Teitler, M.; Fadden, J. S. P.; Glennon, R. A
4-(6-Fluorobenzisoxazol-3-yl)piperidine, a risperidone metabolite with serotonergic activity of potential clinical significance
Med. Chem. Res., 1996, 6, 593-601
No PubMed entry or DOI found

Glennon, R. A.; Dukat, M
5-HT1 receptor ligands: Update 1997
Investigational Drugs Research Alerts, 1997, 2, 351-372
No PubMed entry or DOI found

Teitler, M.; Schieck, C.; Howard, P.; Sullivan, J. E.; Iwamura, T.; Glennon, R. A
5-HT5A serotonin receptors: A preliminary structure-affinity investigation
Med. Chem. Res., 1997, 7, 207-218
No PubMed entry or DOI found

Bondarev, M.; Iwamura, T.; Hynd, D.; Mazzocco, L.; Lee, D. K. H.; Dukat, M.; Glennon, R. A
Aryloxyethylamines as h5-HT1D serotonin receptor ligands
Med. Chem. Res., 1998, 8, 333-342
No PubMed entry or DOI found

Glennon, R. A.; Bondarev, M.; Roth, B
5-HT6 serotonin receptor binding of indolealkylamines: A preliminary structure-affinity investigation
Med. Chem. Res., 1999, 9, 108-117
No PubMed entry or DOI found

Lee, M.; Rangisetty, J. B.; Dukat, M.; Slassi, A.; McClean, N.; Lee, D. K. H.; Glennon, R. A
5-HT6 serotonin receptor binding affinities of N1-benzenesulfonyl and related tryptamines
Med. Chem. Res., 2000, 10, 230-242
No PubMed entry or DOI found

Prisinzano, T.; Law, H.; Slassi, A.; Maclean, N.; Demchyshyn, L.; Glennon, R. A
QSAR studies on 2-(benzyl)imidazoline analogs as 5-HT1B/1D serotonin receptor ligands
Med. Chem. Res., 2001, 10, 309-317
No PubMed entry or DOI found

Wood PL, Pilapil C, LaFaille F, Nair NP, Glennon RA
Unique [3H]tryptamine binding sites in rat brain: distribution and pharmacology
Arch. Int. Pharmacodyn. Ther., 1984, 268(2), 194-201
Medline (PMID=6732364)

Jeffery LH, Glennon RA
Serotonin Receptors, Agents, and Actions
In Drug Design for Neuroscience. ed. Alan P. Kozikowski., Raven Press. Ltd., New York 1993, 167-212
No PubMed entry or DOI found
newbee.jpeg





Stimulants: synthesis and pharmacology (MDMA, MDA, PMMA, (meth)ampehtamine, cathinone, ephedrine, etc.)

Pullagurla M, Bondareva T, Young R, Glennon RA
Modulation of the stimulus effects of (+)amphetamine by the 5-HT(6) antagonist MS-245
Pharmacol. Biochem. Behav., 2004, 78(2), 263-268
Medline (PMID=15219766)

Khorana N, Pullagurla MR, Young R, Glennon RA
Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization
Drug Alcohol. Depend., 2004, 74(3), 281-287
Medline (PMID=15194206)

Rothman RB, Vu N, Partilla JS, Roth BL, Hufeisen SJ, Compton-Toth BA, Birkes J, Young R, Glennon RA
In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates
J. Pharmacol. Exp. Ther., 2003, 307(1), 138-145
Medline (PMID=12954796)
DOI:10.1124/jpet.103.053975
Post 509509 (Red_Crown: "Pharmacology of Ephedrine-related stereoisomers", Stimulants)

Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, Rothman RB, Roth BL
3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro
Mol. Pharmacol., 2003, 63(6), 1223-1229
Medline (PMID=12761331)

Bondareva TS, Young R, Glennon RA
Central stimulants as discriminative stimuli. Asymmetric generalization between (-)ephedrine and S(+)methamphetamine
Pharmacol. Biochem. Behav., 2002, 74(1),157-162
Medline (PMID=12376163)
Post 512466 (7is: "All the missing PBB articles part 2", General Discourse)

Glennon RA, Young R
Effect of 1-(3,4-methylenedioxyphenyl)-2-aminopropane and its optical isomers in PMMA-trained rats
Pharmacol. Biochem. Behav., 2002, 72(1-2), 307-311
Medline (PMID=11900801)
Post 512466 (7is: "All the missing PBB articles part 2", General Discourse)

Dukat M, Young R, Glennon RA
Effect of PMA optical isomers and 4-MTA in PMMA-trained rats
Pharmacol. Biochem. Behav., 2002, 72(1-2), 299-305
Medline (PMID=11900800)
Post 512466 (7is: "All the missing PBB articles part 2", General Discourse)

Young R, Glennon RA
The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline is similar to that of cocaine but different from that of amphetamine
Pharmacol. Biochem. Behav., 2002, 71(1-2), 205-213
Medline (PMID=11812524)
http://www.maps.org/w3pb/new/2002/2002_young_1325_1.pdf

Hong SS, Young R, Glennon RA
Discriminative stimulus properties of alpha-ethyltryptamine optical isomers
Pharmacol. Biochem. Behav., 2001, 70(2-3), 311-316
Medline (PMID=11701202)
https://www.rhodium.ws/pdf/alpha-ethyltryptamine.optical.isomers.pdf

Rangisetty JB, Bondarev ML, Chang-Fong J, Young R, Glennon RA
PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA
Pharmacol. Biochem. Behav., 2001, 69(1-2), 261-267
Medline (PMID=11420094)
Post 512466 (7is: "All the missing PBB articles part 2", General Discourse)

Young R, Glennon RA
Stimulus effects of phenylpropanolamine optical isomers in (+)amphetamine-trained rats
Pharmacol. Biochem. Behav., 2000, 66(3), 489-494
Medline (PMID=10899360)
Post 512466 (7is: "All the missing PBB articles part 2", General Discourse)

Glennon RA, Young R
MDMA stimulus generalization to the 5-HT1A serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin
Pharmacol. Biochem. Behav., 2000, 66(3), 483-438
Medline (PMID=10899359)
Post 512466 (7is: "All the missing PBB articles part 2", General Discourse)

Glennon RA, Young R
(+)Amphetamine-stimulus generalization to an herbal ephedrine product
Pharmacol. Biochem. Behav., 2000, 65(4), 655-658
Medline (PMID=10764918)
Post 512562 (7is: "All the missing PBB articles part 3", General Discourse)

Young R, Bondarev M, Glennon RA
An examination of isomeric phenylpropanolamines in (-)ephedrine-trained rats
Drug Alcohol Depend., 1999, 57(1), 1-6
Medline (PMID=10617308)

Young R, Dukat M, Malmusi L, Glennon RA
Stimulus properties of PMMA: effect of optical isomers and conformational restriction
Pharmacol. Biochem. Behav., 1999, 64(2), 449-453
Medline (PMID=10515329)
Post 512562 (7is: "All the missing PBB articles part 3", General Discourse)
 
Young R, Glennon RA
Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse
Psychopharm. (Berl)., 1998, 140(3), 250-256
Medline (PMID=9877004)

Young R, Gabryszuk M, Glennon RA
(-)Ephedrine and caffeine mutually potentiate one another's amphetamine-like stimulus effects
Pharmacol. Biochem. Behav., 1998, 61(2), 169-173
Medline (PMID=9738532)
Post 512562 (7is: "All the missing PBB articles part 3", General Discourse)

Young R, Glennon RA
Discriminative stimulus properties of (-)ephedrine
Pharmacol. Biochem. Behav., 1998, 60(3), 771-775
Medline (PMID=9678664)
Post 512562 (7is: "All the missing PBB articles part 3", General Discourse)

Dal Cason TA, Young R, Glennon RA
Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs
Pharmacol. Biochem. Behav., 1997, 58(4), 1109-1116
Medline (PMID=9408221)
https://www.rhodium.ws/pdf/cathinone-methylone.pdf

Glennon RA, Young R, Dukat M, Cheng Y
Initial characterization of PMMA as a discriminative stimulus
Pharmacol. Biochem. Behav., 1997, 57(1-2), 151-158
Medline (PMID=9164566)
Post 512562 (7is: "All the missing PBB articles part 3", General Discourse)

Young R, Glennon RA
Cocaine-stimulus generalization to MDA optical isomers: a reevaluation
Pharmacol. Biochem. Behav., 1997, 57(1-2), 115-118
Medline (PMID=9164561)
Post 512562 (7is: "All the missing PBB articles part 3", General Discourse)

Young R, Darmani NA, Elder EL, Dumas D, Glennon RA
Clobenzorex: evidence for amphetamine-like behavioral actions
Pharmacol. Biochem. Behav., 1997, 56(2), 311-316
Medline (PMID=9050090)
Post 512562 (7is: "All the missing PBB articles part 3", General Discourse)

Young R, Glennon RA
A three-lever operant procedure differentiates the stimulus effects of R(-)-MDA from S(+)-MDA
J. Pharmacol. Exp. Ther., 1996, 276(2), 594-601
Medline (PMID=8632326)

Glennon RA, Young R, Martin BR, Dal Cason TA
Methcathione ("cat"): an enantiomeric potency comparison
Pharmacol. Biochem. Behav., 1995, 50(4), 601-606
Medline (PMID=7617707)
Post 512562 (7is: "All the missing PBB articles part 3", General Discourse)

Glennon RA
MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM
Pharmacol. Biochem. Behav., 1993, 46(2), 459-462
Medline (PMID=7903460)
https://www.rhodium.ws/pdf/butanamines/butanamines_1993_PBB.pdf

Young R, Glennon RA
Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex
Pharmacol. Biochem. Behav., 1993, 45(1), 229-231
Medline (PMID=8516363)
Post 512562 (7is: "All the missing PBB articles part 3", General Discourse)

Glennon RA, Higgs R, Young R, Issa H
Further studies on N-methyl-1(3,4-methylenedioxyphenyl)-2-aminopropane as a discriminative stimulus: antagonism by 5-hydroxytryptamine3 antagonists
Pharmacol. Biochem. Behav., 1992, 43(4), 1099-1106
Medline (PMID=1361990)
Post 512562 (7is: "All the missing PBB articles part 3", General Discourse)

Glennon RA, Higgs R
Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline
Pharmacol. Biochem. Behav., 1992, 43(3), 759-763
Medline (PMID=1360162)
Post 512562 (7is: "All the missing PBB articles part 3", General Discourse)

Herndon JL, Pierson ME, Glennon RA
Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine
Pharmacol. Biochem. Behav., 1992, 43(3), 739-748
Medline (PMID=1333084)
Post 512563 (7is: "All the missing PBB articles part 4", General Discourse)
 
Yousif MY, Fitzgerald RL, Narasimhachari N, Rosecrans JA, Blanke RV, Glennon RA
Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats
Drug Alcohol Depend., 1990, 26(2), 127-135
Medline (PMID=1978707)

Glennon RA, Misenheimer B
Stimulus properties of a new designer drug: 4-methylaminorex ("U4Euh")
Pharmacol. Biochem. Behav., 1990, 35(3), 517-521
Medline (PMID=1971111)
Post 512563 (7is: "All the missing PBB articles part 4", General Discourse)
 
Teitler M, Leonhardt S, Appel NM, De Souza EB, Glennon RA
Receptor pharmacology of MDMA and related hallucinogens
Ann N Y Acad Sci., 1990, 600, 626-38, discussion 638-639
Medline (PMID=1979215)

Glennon RA, Misenheimer BR
Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline
Pharmacol. Biochem. Behav., 1989, 33(4), 909-912
Medline (PMID=2575759)
Post 512563 (7is: "All the missing PBB articles part 4", General Discourse)
 
Fitzgerald RL, Blanke RV, Glennon RA, Yousif MY, Rosecrans JA, Poklis A
Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine enantiomers in whole blood
J. Chromatogr., 1989, 490(1), 59-69
Medline (PMID=2760158)

Fitzgerald RL, Blanke RV, Rosecrans JA, Glennon RA
Stereochemistry of the metabolism of MDMA to MDA
Life Sci., 1989, 45(4), 295-301
Medline (PMID=2569654)
Post 508288 (7is: "All the missing Life Sciences articles part 2", General Discourse)

Glennon RA, Ismaiel AE, Martin B, Poff D, Sutton M
A preliminary behavioral investigation of PMMA, the 4-methoxy analog of methamphetamine
Pharmacol. Biochem. Behav., 1988, 31(1), 9-13
Medline (PMID=3252264)
Post 512563 (7is: "All the missing PBB articles part 4", General Discourse)
 
Glennon RA, Yousif M, Patrick G
Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs
Pharmacol. Biochem. Behav., 1988, 29(3), 443-449
Medline (PMID=2896360)
Post 512563 (7is: "All the missing PBB articles part 4", General Discourse)

Rosecrans JA, Glennon RA
The effect of MDA and MDMA ("Ecstasy") isomers in combination with pirenpirone on operant responding in mice
Pharmacol. Biochem. Behav., 1987, 28(1), 39-42
Medline (PMID=2889221)
Post 512563 (7is: "All the missing PBB articles part 4", General Discourse)
 
Glennon RA, Yousif M, Naiman N, Kalix P
Methcathinone: a new and potent amphetamine-like agent
Pharmacol. Biochem. Behav., 1987, 26(3), 547-551
Medline (PMID=3575369)
Post 512563 (7is: "All the missing PBB articles part 4", General Discourse)
 
Glennon RA, Little PJ, Rosecrans JA, Yousif M
The effect of MDMA ("Ecstasy") and its optical isomers on schedule-controlled responding in mice
Pharmacol. Biochem. Behav., 1987, 26(2), 425-426
Medline (PMID=2883666)
Post 512563 (7is: "All the missing PBB articles part 4", General Discourse)
 
Kalix P, Glennon RA
Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone
Biochem Pharmacol., 1986, 35(18), 3015-3019
Medline (PMID=3753515)

Young R, Glennon RA
Discriminative stimulus properties of amphetamine and structurally related phenalkylamines
Med. Res. Rev., 1986, 6(1), 99-130
Medline (PMID=3512936)

Lyon RA, Glennon RA, Titeler M
3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors
Psychopharm. (Berl)., 1986, 88(4), 525-526
Medline (PMID=2871581)

Schechter MD, Glennon RA
Cathinone, cocaine and methamphetamine: similarity of behavioral effects
Pharmacol. Biochem. Behav., 1985, 22(6), 913-916
Medline (PMID=4023025)
Post 512563 (7is: "All the missing PBB articles part 4", General Discourse)
 
Glennon RA, Young R, Hauck AE, McKenney JD
Structure-activity studies on amphetamine analogs using drug discrimination methodology
Pharmacol. Biochem. Behav., 1984, 21(6), 895-901
Medline (PMID=6522418)
Post 496940 (lugh: "Glennon's article", Serious Chemistry)

Glennon RA, Schechter MD, Rosecrans JA
Discriminative stimulus properties of S(-)- and R(+)-cathinone, (+)-cathine and several structural modifications
Pharmacol. Biochem. Behav., 1984, 21(1), 1-3
Medline (PMID=6463083)
Post 512563 (7is: "All the missing PBB articles part 4", General Discourse)
 
Aceto MD, Rosecrans JA, Young R, Glennon RA
Similarity between (+)-amphetamine and amfonelic acid
Pharmacol. Biochem. Behav., 1984, 20(4), 635-637
Medline (PMID=6728880)
Post 512563 (7is: "All the missing PBB articles part 4", General Discourse)
 
Glennon RA, Young R
Further investigation of the discriminative stimulus properties of MDA
Pharmacol. Biochem. Behav., 1984, 20(4), 501-505
Medline (PMID=6728867)
Post 512565 (7is: "All the missing PBB articles part 5", General Discourse)
 
Glennon RA, Young R
MDA: an agent that produces stimulus effects similar to those of 3,4-DMA, LSD and cocaine
Eur. J. Pharmacol., 1984, 99(2-3), 249-250
Medline (PMID=6145599)

Schechter MD, Rosecrans JA, Glennon RA
Comparison of behavioral effects of cathinone, amphetamine and apomorphine
Pharmacol. Biochem. Behav., 1984, 20(2), 181-184
Medline (PMID=6718445)
Post 512565 (7is: "All the missing PBB articles part 5", General Discourse)

Glennon RA, Young R
MDA: a psychoactive agent with dual stimulus effects
Life Sci., 1984, 34(4), 379-383
Medline (PMID=6694526)
Post 508287 (not existing)
 
Glennon RA, Young R, Soine W
1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation
Gen. Pharmacol., 1984, 15(4), 361-362
Medline (PMID=6149169)

Glennon RA, Young R, Rosecrans JA, Anderson GM
Discriminative stimulus properties of MDA analogs
Biol. Psychiatry, 1982, 17(7), 807-814
Medline (PMID=6126227)

Glennon RA, Liebowitz SM
Serotonin receptor affinity of cathinone and related analogues
J. Med. Chem., 1982, 25(4), 393-397
Medline (PMID=7069716)


Glennon, R. A.; Showalter, D
The Effects of Cathinone and Several Related Derivatives on Locomotor Activity
Res. Commun. Subst. Abuse 1981, 2, 186
No PubMed entry or DOI found

Kalix, P.; Yousif, M. Y.; Glennon, R. A
Differential effect of the enantiomers of methylenedioxyamphetamine (MDMA) on the release of radioactivity from [3H]dopamine-prelabeled rat striatum
Res. Commun. Substance Abuse 1988, 9, 45-51
No PubMed entry or DOI found

Glennon, R. A.; Misenheimer, B
Stimulus effects of N-mono ethyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline
Pharmacol. Biochem. Behav., 1989, 33, 900-912
No PubMed entry or DOI found

Dal Cason, T.; Young, R.; Glennon, R. A
Cathinone: An investigation of several N-alkyl and methylenedioxy-substituted analogs
Pharmacol. Biochem. Behav., 1997, 58, 1109-1116
No PubMed entry or DOI found

Young, R.; Gabryszuk, M.; Glennon, R. A
(-)Ephedrine and caffeine mutually potentiate one anothers amphetamine-like stimulus effects
Pharmacol. Biochem. Behav., 1998, 61, 169-173
No PubMed entry or DOI found

Young, R.: Glennon, R. A
Discriminative stimulus properties of (-)ephedrine
Pharmacol. Biochem. Behav., 1998, 60, 771-775
No PubMed entry or DOI found

Glennon, R. A.; Young, R
(+)Amphetamine stimulus generalization to an herbal ephedrine product
Pharmacol. Biochem. Behav., 2000, 65, 655-658
No PubMed entry or DOI found

Malmusi, L.; Dukat, M.; Young, R.; Teitler, M.; Darmani, N.; Ahmad, B.; Smith, C.; Glennon, R. A
1,2,3,4- Tetrahydroisoquinolines and related analogs of the phenylalkylamine designer drug MDMA
Med. Chem. Res., 1996, 6, 412-426
No PubMed entry or DOI found






The sigma receptor

Ablordeppey SY, Fischer JB, Law H, Glennon RA
Probing the proposed phenyl-A region of the sigma-1 receptor
Bioorg. Med. Chem., 2002, 10(8), 2759-2265
Medline (PMID=12057665)
newbee.jpeg

Ablordeppey SY, Fischer JB, Glennon RA
Is a nitrogen atom an important pharmacophoric element in sigma ligand binding?
Bioorg. Med. Chem., 2000, 8(8), 2105-2111
Medline (PMID=11003156)
newbee.jpeg

Glennon RA, Ablordeppey SY, Ismaiel AM, el-Ashmawy MB, Fischer JB, Howie KB
Structural features important for sigma 1 receptor binding
J. Med. Chem., 1994, 37(8), 1214-1219
Medline (PMID=8164264)

Glennon RA, Yousif MY, Ismaiel AM, el-Ashmawy MB, Herndon JL, Fischer JB, Server AC, Howie KJ
Novel 1-phenylpiperazine and 4-phenylpiperidine derivatives as high-affinity sigma ligands
J. Med. Chem., 1991, 34(12), 3360-3365
Medline (PMID=1662725)

Glennon RA, Ismaiel AM, Smith JD, Yousif M, el-Ashmawy M, Herndon JL, Fischer JB, Howie KJ, Server AC
Binding of substituted and conformationally restricted derivatives of N-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane at sigma-receptors
J. Med. Chem., 1991, 34(6), 1855-1859
Medline (PMID=1648139)
newbee.jpeg

Glennon RA, Smith JD, Ismaiel AM, el-Ashmawy M, Battaglia G, Fischer JB
Identification and exploitation of the sigma-opiate pharmacophore
J. Med. Chem., 1991, 34(3), 1094-1098
Medline (PMID=1848295)

Glennon RA, Battaglia G, Smith JD
(-)PPAP: a new and selective ligand for sigma binding sites
Pharmacol. Biochem. Behav., 1990, 37(3), 557-559
Medline (PMID=1965044)
Post 512565 (7is: "All the missing PBB articles part 5", General Discourse)

Glennon, R.A., El-Ashmawy, M., Fischer, J.B., Burke Howie, K.J., Ismaiel, A.M
N-Substituted 5-phenyl pentylamines: A new class of s receptor ligands
Med. Chem. Res., 1991, 1, 207-212
No PubMed entry or DOI found

Ablordeppey, S.Y.; El-Ashmawy, M. B.; Glennon, R.A
Analysis of the structure-activity relationships of sigma receptor ligands
Med. Chem. Res. 1991, 1, 425-438
No PubMed entry or DOI found

El-Ashmawy, M.; Ablordeppey, S.Y.; Issa, H.; Gad, L.; Fischer, J.B.; Burke Howie, K. J.; Glennon, R. A
Further investigation of 5-phenylpentylamine derivatives as novel s receptor ligands
Med. Chem. Res., 1992, 2, 119-126
No PubMed entry or DOI found

Ablordeppey, S.Y.; El-Ashmawy, M. B.; Glennon, R.A
Analysis of the structure-activity relationships of sigma receptor ligands
Med. Chem. Res., 1992, 2, 425-438
No PubMed entry or DOI found

Ablordeppey, S.Y.; Fischer, J.B.; Burke Howie, K.J.; Glennon, R.A
Design, synthesis and binding of sigma receptor ligands derived from butaclamol
Med. Chem. Res., 1992, 2, 368-375
No PubMed entry or DOI found

Abou-Gharbia, M.; Ablordeppey, S.Y.; Glennon, R.A
Sigma receptors and their ligands: The Sigma Enigma
Ann. Rep. Med. Chem., 1993, 28, 1-10
No PubMed entry or DOI found

Ablordeppey, SY; Ashmawy, M.; Fischer, J. B.; Glennon, R. A
A CoMFA investigation of sigma receptor binding affinity: Reexamination of a spurious sigma ligand
Eur. J. Med. Chem., 1998, 33, 625-633
No PubMed entry or DOI found

Ablordeppey, SY; Issa, H; Fischer, JB; Burke Howie, KJ; Glennon, RA
Synthesis and structure-affinity relationship studies of sigma ligands related to haloperidol
Med. Chem. Res., 1993, 3, 131-138
No PubMed entry or DOI found





Articles dealing with synthetic methods

Glennon, R. A.; Bass, R. G.; Schubert, E
Alkylation of thiazolo[3,2-a]pyrimidin-5,7-diones
J. Heterocyclic Chem., 1979, 16, 903
No PubMed entry or DOI found

Glennon, R. A.; Rogers, M. E.; El-Said, M. K
Imidazo[1,2a]-pyrimidines and 1,2,4-triazolo[1,5-a]pyrimidines: Two new examples of mesoionic xanthine analogs
J. Heterocyclic Chem., 1980, 17, 337
No PubMed entry or DOI found

Glennon, R. A.; Schubert, E.; Bass, R. G
Synthesis of Mesoionic Xanthine Nucleosides
Tetrahedron Lett. 1981, 29, 2753
No PubMed entry or DOI found

Salley, J. J.; Glennon, R. A
Studies on Simplified Ergoline Derivatives. A General Six-step Synthesis of Phenyl- Substituted4-Methyl-3,4a,5,6,10b-hexahydrobenzo[f]quinolin-1(2H)-one Analogs
J. Heterocyclic Chem., 1982, 19, 545
No PubMed entry or DOI found

Schubert, E. M.; Bass, R. G.; Glennon, R. A
Synthesis of mesoionic xanthine nucleosides
Nucleosides/ Nucleotides, 1983, 2, 127
No PubMed entry or DOI found

Mbagwu, G.; Bass, R. G.; Glennon, R. A
Carbon-13 Nuclear Magnetic Resonance Spectra of some Mesoionic Xanthine Analogs
Org. Magnetic Res., 1983, 21, 527
No PubMed entry or DOI found

Glennon, R. A.; Tejani, S
Mesoionic Nucleosides: Studies on Mesoionic Imidazo[2,1-b]-1,3-thiazine Derivatives
Nucleosides/Nucleotides, 1984, 3, 389
No PubMed entry or DOI found

Schubert, E. M.; Schram, K. H.; Glennon, R. A
Mass spectrometry of modified nucleic acid bases and nucleosides. Class II mesoionic nucleosides and bases derived from thiazolo[3,2-a]pyrimidine-5,7-diones
J. Heterocyclic. Chem., 1985, 22, 889
No PubMed entry or DOI found

Mbagwu, G. O.; Bass, R. G.; Glennon, R. A
Studies of amine-induced ring-opening of some mesoionic xanthines
J. Heterocyclic Chem., 1985, 22, 465
No PubMed entry or DOI found

Kerdawy, M.; Bayomi, S.; Shehata, I; Glennon, R. A
Condensed 1,2,3-triazines: 1,3,4-thiadiazolo[3,2-a]-1,3, 5-triazines and isoxazolo[2,3-a]-1,3,5-triazines
J. Heterocyclic Chem., 1987, 24, 501-504
No PubMed entry or DOI found

Shehata, I.; Glennon, R. A
Mesoionic isoxazolo[2,3-a]pyrimidindiones and 1,3,4-oxadiazolo[3,2-a]- pyrimidindiones as potential adenosine antagonists
J. Heterocyclic Chem., 1987, 24, 1291-1295
No PubMed entry or DOI found

Kerdawy, M. M.; Ismaiel, A. M.; Gineinah, M.; Glennon, R. A
A convenient synthesis of 3-aryl-1,2,4-triazolo [4,3-c]quinazolines
J. Heterocyclic Chem., 1990, 27, 497-501
No PubMed entry or DOI found

Gineinah, M.; Ismaiel, A. M.; Kerdawy, M.; Glennon, R. A
Mesoionic 1,2,4-triazolo[4,3-c]quinazolines
J. Heterocyclic Chem., 1990, 27, 723-726
No PubMed entry or DOI found

Coburn, R. A.; Carapellotti, R. A.; Glennon, R. A
A PPP p-SCF variable integral study of mesoionic analogs based on six-membered ring mesoionic systems
J. Heterocyclic Chem., 1973, 10, 479
No PubMed entry or DOI found

Coburn, R. A.; Glennon, R. A
Synthesis and properties of mesoionic thiazolo[3,2-a]pyrimidin-5,7-diones
J. Heterocyclic Chem., 1973, 10, 487
No PubMed entry or DOI found

Coburn, R. A.; Bhooshan, B.; Glennon, R. A
The preparation of 2-alkylamino-1,3,4-thiadiazoles
J. Org. Chem., 1973, 38, 3947
No PubMed entry or DOI found

Glennon, R. A.; Von Strandtmann, M
Cyclodehydration of N-heteroarylcarbamoylmethylbenzamides
J. Heterocyclic Chem., 1975, 12, 135
No PubMed entry or DOI found






The nicotinic acetyl choline receptor

Glennon RA, Dukat M
alpha4beta2 nACh receptor pharmacophore models
Bioorg. Med. Chem. Lett., 2004, 14(8), 1841-1844
Medline (PMID=15050612)

Glennon RA, Dukat M, Liao L
Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models
Curr. Top. Med. Chem., 2004, 4(6), 631-644
Medline (PMID=14965299)

Dogruer D, Lee M, Dukat M, Damaj MI, Martin BR, Glennon RA
3-(4-Aminobutyn-1-yl)pyridines: binding at alpha4beta2 nicotinic cholinergic receptors
Bioorg. Med. Chem. Lett., 2004, 14(2), 523-526
Medline (PMID=14698195)

Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA
Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors
Bioorg. Med. Chem. Lett., 2003, 13(4), 733-735
Medline (PMID=12639569)

Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA
Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding
J. Med. Chem., 2002, 45(21), 4724-4731
Medline (PMID=12361399)

Dukat M, El-Zahabi M, Ferretti G, Damaj MI, Martin BR, Young R, Glennon RA
(-)6-n-Propylnicotine antagonizes the antinociceptive effects of (-)nicotine
Bioorg. Med. Chem. Lett., 2002, 12(20), 3005-3007
Medline (PMID=12270194)

Lee M, Dukat M, Liao L, Flammia D, Damaj MI, Martin B, Glennon RA
A comparison of the binding of three series of nicotinic ligands
Bioorg. Med. Chem. Lett., 2002, 12(15), 1989-1992
Medline (PMID=12113825)

Young R, Glennon RA
Nicotine and bupropion share a similar discriminative stimulus effect
Eur. J. Pharmacol., 2002, 443(1-3), 113-118
Medline (PMID=12044800)

Dukat M, Damaj IM, Young R, Vann R, Collins AC, Marks MJ, Martin BR, Glennon RA
Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations
Eur. J. Pharmacol., 2002, 435(2-3), 171-180
Medline (PMID=11821023)

Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA
Chain-lengthened and imidazoline analogues of nicotine
Bioorg. Med. Chem. Lett., 2000, 10(23), 2665-2668
Medline (PMID=11128647)

Glennon RA, Dukat M
Central nicotinic receptor ligands and pharmacophores
Pharm. Acta Helv., 2000, 74(2-3), 103-114
Medline (PMID=10812946)

Flammia D, Dukat M, Damaj MI, Martin B, Glennon RA
Lobeline: structure-affinity investigation of nicotinic acetylcholinergic receptor binding
J. Med. Chem., 1999, 42(18), 3726-3731
Medline (PMID=10479304)

Damaj MI, Fei-Yin M, Dukat M, Glassco W, Glennon RA, Martin BR
Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice
J. Pharmacol. Exp. Ther., 1998, 284(3), 1058-1065
Medline (PMID=9495867)

Glennon, R.A.; Maarouf, R.; Fahmy, S.; Martin, B.; Fan, F.; Yousif, M.; Shafik, R.; Dukat, M
Structure-affinity relationships of simple nicotine analogs
Med. Chem. Res., 1993, 2, 546-551
No PubMed entry or DOI found

Dukat, M.; Damaj, M. I.; Glassco, W.; Dumas, D.; May, E. L.; Martin, B. R.; Glennon, R. A
Epibatidine: A very high affinity nicotine-receptor ligand
Med. Chem. Res., 1994, 4, 131-139
No PubMed entry or DOI found

Glennon, R.A.; Herndon, J.; Dukat, M
Epibatidine-aided studies toward definition of a nicotine receptor pharmacophore
Med. Chem. Res., 1994, 4, 461-473
No PubMed entry or DOI found

Glennon, R.A.; Fiedler, W.; Dukat, M.; Damaj, I.; Martin, B
Pyrrolidine-modified analogues of nicotine: a structure-affinity investigation
Eur. J. Med. Chem., 1996, 31, 875-888
No PubMed entry or DOI found

Glennon, R. A.; Dukat, M
Nicotine receptor ligands
Med. Chem. Res., 1996, 6, 465-486
No PubMed entry or DOI found

Damaj, M. I.; Glassco, W.; Dukat, M.; May, E. L.; Glennon, R. A.; Martin, B. R
Pharmacology of novel nicotinic analogs
Drug Dev. Res., 1996, 38, 177-187
No PubMed entry or DOI found

Dukat, M.; Dowd, M.; Damaj, M. I.; Martin, B.; El-Zahabi, M. A.; Glennon, R. A
Synthesis, receptor binding, and QSAR studies on 6-subtituted nicotine derivatives as cholinergic ligands
Eur. J. Med. Chem., 1999, 34, 31-40
No PubMed entry or DOI found

Cheng, Y.-X.; Dukat, M.; Dowd, M.; Fiedler, W.; Martin, B.; Damaj, M. I.; Glennon, R. A
Synthesis and binding of 6,7,8,9-tetrahydro-5H-pyrido[3,4-d]azepine and related ring-opened analogs at central nicotinic receptors
Eur. J. Med. Chem., 1999, 34, 177-190
No PubMed entry or DOI found

Dukat M, Glennon RA
Epibatidine: impact on nicotinic receptor research
Cell. Mol. Neurobiol., 2003, 23(3), 365-378
Medline (PMID=12825833)







The imidazoline receptor

Tyacke RJ, Lau A, Grella B, Glennon RA, Nutt DJ, Hudson AL
Investigation of the affinities of two new beta-carbolines for rat brain imidazoline(2) receptors
Ann N Y Acad Sci., 2003, 1009, 361-363
Medline (PMID=15028612)

Chang-Fong J, Tyacke RJ, Lau A, Westaway J, Hudson AL, Glennon RA
Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I(2) receptor ligands
Bioorg. Med. Chem. Lett., 2004, 14(4), 1003-1005
Medline (PMID=15013010)

Glennon RA, Grella B, Tyacke RJ, Lau A, Westaway J, Hudson AL
Binding of beta-carbolines at imidazoline I2 receptors: a structure-affinity investigation
Bioorg. Med. Chem. Lett., 2004, 14(4), 999-1002
Medline (PMID=15013009)

Glennon RA, Grella B, Tyacke RJ, Lau A, Westaway J, Hudson AL
Binding of an imidazopyridoindole at imidazoline I2 receptors
Bioorg. Med. Chem. Lett., 2004, 14(2), 527-529
Medline (PMID=14698196)

Husbands SM, Glennon RA, Gorgerat S, Gough R, Tyacke R, Crosby J, Nutt DJ, Lewis JW, Hudson AL
beta-carboline binding to imidazoline receptors
Drug Alcohol Depend., 2001, 64(2), 203-208
Medline (PMID=11543990)
Post 494854 (Nicodem: "Papers on beta-carbolines", General Discourse)





Articles on various subjects

Dukat M, Taroua M, Dahdouh A, Siripurapu U, Damaj MI, Martin BR, Glennon RA
(+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents
Bioorg. Med. Chem. Lett., 2004, 14(14), 3651-3654
Medline (PMID=15203136)

Glennon RA, Ismaiel AM, Ablordeppey S, El-Ashmawy M, Fisher JB
Thioxanthene-derived analogs as [Formula: see text] receptor ligands
Bioorg. Med. Chem. Lett., 2004, 14(9), 2217-2220
Medline (PMID=15081012)
Post 508287 (not existing)

Glennon RA
[In Process Citation]
Prog. Med. Chem., 2004, 42, 55-123
Medline (PMID=15003719)

Simsek R, Chang-Fong J, Lee M, Dukat M, Imad Damaj M, Martin BR, Glennon RA
Quaternary ammonium 3-(aminoethoxy)pyridines as antinociceptive agents
Bioorg. Med. Chem. Lett., 2003, 13(17), 2917-2920
Medline (PMID=14611857)

Bondarev ML, Bondareva TS, Young R, Glennon RA
Behavioral and biochemical investigations of bupropion metabolites
Eur. J. Pharmacol., 2003, 474(1), 85-93
Medline (PMID=12909199)

Glennon RA, Young R, Rangisetty JB
Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline
Pharmacol. Biochem. Behav., 2002, 72(1-2), 379-387
Medline (PMID=11900809)
https://www.rhodium.ws/pdf/glennon.2002.tdiq.pdf

Hellberg M, Stubbins JF, Glennon RA
A preliminary investigation of mesoionic xanthine analogues as inhibitors of platelet aggregation
Bioorg. Med. Chem., 2000, 8(8), 1917-1923
Medline (PMID=11003136)

Glennon RA, Dukat M, Westkaemper RB, Ismaiel AM, Izzarelli DG, Parker EM
The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine
Mol. Pharmacol., 1996, 49(1), 198-206
Medline (PMID=8569707)

Damaj MI, Glennon RA, Martin BR
Involvement of the serotonergic system in the hypoactive and antinociceptive effects of nicotine in mice
Brain Res. Bull., 1994, 33(2), 199-203
Medline (PMID=8275340)

Glennon RA, Young R, Herndon JL
Antagonism of a (+)N-allylnormetazocine stimulus by (-)PPAP and several structurally related analogs
Pharmacol. Biochem. Behav., 1993, 45(4), 865-869
Medline (PMID=8105490)
Post 512565 (7is: "All the missing PBB articles part 5", General Discourse)

Young R, Glennon RA
Zacopride and its optical isomers produce stereoselective antagonism of a 2-methylserotonin discriminative stimulus
Eur. J. Pharmacol., 1992, 212(1), 117-119
Medline (PMID=1555633)

Glennon RA, De Vry J, Spencer DG Jr, Glaser T
Stimulus properties of tiflucarbine: a novel antidepressant agent
Pharmacol. Biochem. Behav., 1990, 37(4), 769-771
Medline (PMID=2151199)
Post 512565 (7is: "All the missing PBB articles part 5", General Discourse)

Glennon RA, Pierson ME, McKenney JD
Stimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol, and mesulergine
Pharmacol. Biochem. Behav., 1988, 29(1), 197-199
Medline (PMID=2895480)
Post 512565 (7is: "All the missing PBB articles part 5", General Discourse)

Young R, Glennon RA
Stimulus properties of benzodiazepines: correlations with binding affinities, therapeutic potency, and structure activity relationships (SAR)
Psychopharm. (Berl)., 1987, 93(4), 529-533
Medline (PMID=2893418)

Young R, Glennon RA, Dewey WL
Effects of pyrazolopyridines and a triazolopyridazine on the pentobarbital discriminative stimulus
Psychopharm. (Berl)., 1987, 93(4), 494-497
Medline (PMID=2893416)

Young R, Glennon RA, Brase DA, Dewey WL
Potencies of diazepam metabolites in rats trained to discriminate diazepam
Life Sci., 1986, 39(1), 17-20
Medline (PMID=3088348)

Glennon RA, Tejani-Butt SM, Padgett W, Daly JW
Mesoionic xanthine analogues: antagonists of adenosine receptors
J. Med. Chem., 1984, 27(10), 1364-1367
Medline (PMID=6090665)

Young R, Glennon RA, Dewey WL
Stereoselective stimulus effects of 3-methylflunitrazepam and pentobarbital
Life Sci., 1984, 34(20), 1977-1983
Medline (PMID=6328149)
Post 508287 (not existing)

Lund MQ, Kier LB, Glennon RA, Egle JL Jr
Preliminary studies of mesoionic 3-(substituted-aryl)-psi-oxatriazoles as potential antihypertensive agents
J. Med. Chem., 1982, 25(12), 1503-1505
Medline (PMID=7154013)

Rogers ME, Glennon RA, Smith JD, Boots MR, Nanavati N, Maconaughey E, Aub D, Thomas S, Bass RG, Mbagwu G
Mesoionic purinone analogues as inhibitors of cyclic-AMP phosphodiesterase: a comparison of several ring systems
J. Med. Chem., 1981, 24(11), 1284-1287
Medline (PMID=6273558)

Glennon RA, Salley JJ Jr, Steinsland OS, Nelson S
Synthesis and evaluation of novel alkylpiperazines as potential dopamine antagonists
J. Med. Chem., 1981, 24(6), 678-683
Medline (PMID=7252977)

Glennon RA, Gaines JJ, Rogers ME
Benz-fused mesoionic xanthine analogues as inhibitors of cyclic-AMP phosphodiesterase
J. Med. Chem., 1981, 24(6), 766-769
Medline (PMID=6265639)

Glennon RA, Rogers ME, Smith JD, El-Said MK, Egle JL
Mesoionic xanthine analogues: phosphodiesterase inhibitory and hypotensive activity
J. Med. Chem., 1981, 24(6), 658-661
Medline (PMID=6265635)

Glennon RA, Schubert E, Jacyno JM, Rosecrans JA
Studies on several 7-substituted N,N-dimethyltryptamines
J. Med. Chem. 1980, 23(11), 1222-1226
Medline (PMID=6779006)
https://www.rhodium.ws/pdf/7-substituted.dmt.pdf

Rosecrans JA, Glennon RA
Drug-induced cues in studying mechanisms of drug action
Neuropharmacology. 1979, 18(12), 981-989
Medline (PMID=530379)

Glennon RA, Rogers ME, Bass RG, Ryan SB
Mesoionic xanthine analogs as inhibitors of cyclic AMP phosphodiesterase
J. Pharm. Sci., 1978, 67(12), 1762-1765
Medline (PMID=214541)

Coburn RA, Glennon RA
Mesoionic purinone analogs. 7. In vitro antibacterial activity of mesoionic 1,3,4-thiadiazolo(3,2-a)pyrimidine-5,7-diones
J. Med. Chem., 1974, 17(9), 1025-1027
Medline (PMID=4213245)

Coburn RA, Glennon RA
Mesoionic purinone analogs. IV. Synthesis and in vitro antibacterial properties of mesoionic thiazolo(3,2-a)pyrimidin-5,7-diones and mesoionic 1,3,4-thiadizolo(3,2-a)pyrimidin-5,7-diones
J. Pharm. Sci., 1973, 62(11), 1785-1789
Medline (PMID=4202220)

Watson, H.; Glennon, R.A
Common drug interactions
Anesthesia Update, 1978, 6, 1
No PubMed entry or DOI found

Young, R.; Glennon, R. A.; Brase, D.; Dewey, W. L
Potencies of diazepam metabolites in generalizing to the diazepam discriminative stimulus
Life Sci., 1985, 39, 17
No PubMed entry or DOI found

The tendency is to push it as far as you can
 
 

   
   

 https://the-hive.archive.erowid.org    the-hive@erowid.org
   
Powered by PCP-Nuke V. 3.06, 2017-2019, Living Light

Links     Erowid     Rhodium

PIHKAL     TIHKAL     Total Synthesis II

Date: 09-08-24, Release: 1.6 (10-04-15), Links: static, unique